Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2025-12-24 @ 9:23 PM
NCT ID:
NCT05190432
Eligibility Criteria:
Inclusion Criteria:
* age 50-65yr
* BMI 18.5-30kg/m2
* Willing to avoid consumption of foods rich in Taxifolin/DHQ and Ergothioneine during the study period
* Willing to avoid taking any other food supplements or high doses of vitamins during the study period
* Able to provide written informed consent.
Exclusion Criteria:
* Use of prescription medication which may influence immune function, such as anti-inflammatory or immunosuppressant medication
* Diabetes requiring any medication
* Liver cirrhosis
* A history of drug or alcohol misuse
* Asplenia or other acquired or congenital immunodeficiencies
* Any autoimmune disease including connective tissue diseases
* Malignancy
* Laboratory confirmed SARS-CoV-2 infection within last 3 months
* self-reported symptoms of acute or recent infection (including use of antibiotics within the last 3 months)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
65 Years
Study:
NCT05190432
Study Brief:
Protocol Section:
NCT05190432